Application Nr Approved Date Route Status External Links
NDA202497 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Marqibo Is A Vinca Alkaloid Indicated For The Treatment Of Adult Patients With Philadelphia Chromosome-Negative (Ph-) Acute Lymphoblastic Leukemia (All) In Second Or Greater Relapse Or Whose Disease Has Progressed Following Two Or More Anti-Leukemia Therapies. This Indication Is Based On Overall Response Rate. Clinical Benefit Such As Improvement In Overall Survival Has Not Been Verified ( 1.1 ). 1.1 Adult All In Second Or Greater Relapse Marqibo ® Is Indicated For The Treatment Of Adult Patients With Philadelphia Chromosome-Negative (Ph-) Acute Lymphoblastic Leukemia (All) In Second Or Greater Relapse Or Whose Disease Has Progressed Following Two Or More Anti-Leukemia Therapies. This Indication Is Based On Overall Response Rate. Clinical Benefit Such As Improvement In Overall Survival Has Not Been Verified.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Vincristine Sulfate VINCRISTINE SULFATE ZINC85432549

Comments